Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Pediatric Clinics of North America|June 12, 2010
Preventing injuries and illnesses in the wildernessDavid Angert, Eric A SchaffThe Journal of Family Practice|October 22, 2013
Oral contraceptives: does formulation matter?Kathryn A Szabo, Eric A SchaffQualitative Health Research|April 27, 2004
Social context and the experience of a sample of U.S. women taking RU-486 (mifepristone) for early abortionStephen L Fielding, Eric A SchaffCurrent Treatment Options in Cardiovascular Medicine|July 25, 2009
Stem cell therapy for heart failureDavid Angert, Steven R HouserContraception|November 5, 2002
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancyEric A Schaff, Stephen L Fielding, Carolyn WesthoffContraception|January 11, 2005
Comparison of misoprostol plasma concentrations following buccal and sublingual administrationEric A Schaff, Robert DiCenzo, Stephen L FieldingPerspectives on Sexual and Reproductive Health|May 7, 2002
Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiencesStephen L Fielding, Emme Edmunds, Eric A SchaffContraception|August 10, 2002
Clinicians' perception of sonogram indication for mifepristone abortion up to 63 daysStephen L Fielding, Eric A Schaff, Na-yon NamClinical and Translational Science|May 7, 2010
c-Kit+ bone marrow stem cells differentiate into functional cardiac myocytesHajime Kubo, Remus M Berretta, Naser Jaleel, et al.Pageof 2